Gastro-esophageal reflux disease (GERD) is associated with a variety of typical and atypical symptoms.
Patients often present in the first instance to a pharmacist or primary care physician and are subsequently referred to secondary care if initial management fails.
|PPIs will remain a prominent treatment for GERD|
|Alimentary Pharmacology & Therapeutics|
Guidelines usually do not provide a clear guidance for all healthcare professionals with whom the patient may consult.
Dr Tytgat and colleagues from the Netherlands updated a 2002-treatment algorithm for GERD, making it more applicable to pharmacists as well as doctors.
The team investigated the triggers for heartburn and adjuvant therapies for rapid and adequate symptom relief.
The researchers found that proton pump inhibitors (PPIs) will remain a prominent treatment for GERD.
However, the use of antacids and alginate-antacids, either alone or in combination with acid suppressants, is likely to increase.
Dr Tytgat's team concluded, "The newly developed algorithm takes into account latest clinical practice experience, offering healthcare professionals clear and effective treatment options for the management of GERD."